MedPath

Oligo-G

Generic Name
Oligo-G

A Cross-over Study of OligoG in Subjects With Cystic Fibrosis. Fibrosis

Phase 1
Completed
Conditions
Cystic Fibrosis
Interventions
First Posted Date
2011-11-04
Last Posted Date
2015-01-14
Lead Sponsor
AlgiPharma AS
Target Recruit Count
26
Registration Number
NCT01465529
Locations
🇮🇪

Beaumont Hospital, Dublin, Ireland

🇮🇪

University College Hospital Galway, Galway, Ireland

🇬🇧

Liverpool Heart & Chest Hospital, Liverpool, United Kingdom

Safety and Efficacy of Inhaled OligoG CF-5/20 for the Treatment Cystic Fibrosis

Phase 1
Completed
Conditions
Cystic Fibrosis
Interventions
First Posted Date
2009-09-02
Last Posted Date
2016-03-23
Lead Sponsor
AlgiPharma AS
Target Recruit Count
26
Registration Number
NCT00970346
© Copyright 2025. All Rights Reserved by MedPath